ArticleDiscover mental health2025
Transitioning from deceptive to nondeceptive placebo treatment to reduce pathological skin-picking.
Article in Discover mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDeceptive placebos (DPs) have been shown to alleviate symptoms of several mental disorders. However, the willingness of patients to transition from DP treatment to nondeceptive placebos (NDPs) has not been systematically investigated.
methodThis study examined whether individuals with pathological skin-picking (n = 69), who were initially administered oral capsules labeled as N-acetylcysteine (DPs; one per day over two weeks), would consent to continue the same treatment regimen when the capsules were presented as NDPs. The DP and NDP treatments were compared in terms of their reported effectiveness in reducing skin-picking symptoms and difficulties in emotion regulation. The average duration between the start of the DP and NDP trials was 17.4 weeks. Additionally, participants indicated their preference for DP or NDP treatment in an open-ended format.
resultsFollowing debriefing after the DP trial, 20 participants (mean age = 32 years; male-to-female ratio 1:19) agreed to enter the NDP trial. On average, these participants had reported clinically meaningful symptom reduction during the DP phase. By the end of the study, only four participants expressed a preference for NDPs, which did not result in statistically significant symptom reduction.
conclusionThe benefits of DP treatment for pathological skin-picking did not carry over to NDPs. Future research could explore whether extended psychoeducation increases the number of NDP responders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.